Abametapir 0.74% (Xeglyze) for the treatment of head lice

Publication Type:Journal Article
Year of Publication:2022
Authors:M. Sunder
Journal:American Family Physician
Volume:106
Issue:1
Pagination:91-92
Date Published:July 2022
Abstract:

Abametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for the treatment of head lice infestation in patients six months and older

URL:https://www.aafp.org/pubs/afp/issues/2022/0700/steps-abametapir-head-lice.html
Tue, 2024-01-16 15:04 -- Yokb
Scratchpads developed and conceived by (alphabetical): Ed Baker, Katherine Bouton Alice Heaton Dimitris Koureas, Laurence Livermore, Dave Roberts, Simon Rycroft, Ben Scott, Vince Smith